Kimia Biosciences (BOM:530313) FCF Yield % : 0.00 (As of Jun. 05, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kimia Biosciences's Trailing 12-Month Free Cash Flow is ₹0.00 Mil, and Market Cap is ₹2,302.71 Mil. Therefore, Kimia Biosciences's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Kimia Biosciences's FCF Yield % or its related term are showing as below:

BOM:530313's FCF Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: -0.19
* Ranked among companies with meaningful FCF Yield % only.

Kimia Biosciences's FCF Margin % for the quarter that ended in . 20 was 0.00%.

Kimia Biosciences FCF Yield % Historical Data

The historical data trend for Kimia Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences FCF Yield % Chart

Kimia Biosciences Annual Data

Trend

FCF Yield %

Kimia Biosciences Semi-Annual Data

FCF Yield %

Competitive Comparison of Kimia Biosciences's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's FCF Yield % falls into.

Kimia Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kimia Biosciences's FCF Yield % for the fiscal year that ended in . 20 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=		/
	=	N/A%

Kimia Biosciences's annualized FCF Yield % for the quarter that ended in . 20 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=		*	1	/
	=	N/A%

Kimia Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kimia Biosciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kimia Biosciences (BOM:530313) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » FCF Yield %

Traded in Other Exchanges

N/A

Address

Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034

Website

https://www.kimiabiosciences.com

Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines